全文获取类型
收费全文 | 2115篇 |
免费 | 120篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 86篇 |
妇产科学 | 39篇 |
基础医学 | 234篇 |
口腔科学 | 51篇 |
临床医学 | 234篇 |
内科学 | 527篇 |
皮肤病学 | 30篇 |
神经病学 | 83篇 |
特种医学 | 319篇 |
外科学 | 304篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 80篇 |
眼科学 | 24篇 |
药学 | 120篇 |
中国医学 | 1篇 |
肿瘤学 | 114篇 |
出版年
2022年 | 17篇 |
2021年 | 21篇 |
2020年 | 23篇 |
2019年 | 22篇 |
2018年 | 34篇 |
2017年 | 31篇 |
2016年 | 40篇 |
2015年 | 41篇 |
2014年 | 49篇 |
2013年 | 70篇 |
2012年 | 84篇 |
2011年 | 104篇 |
2010年 | 90篇 |
2009年 | 79篇 |
2008年 | 79篇 |
2007年 | 97篇 |
2006年 | 96篇 |
2005年 | 92篇 |
2004年 | 68篇 |
2003年 | 59篇 |
2002年 | 63篇 |
2001年 | 57篇 |
2000年 | 33篇 |
1999年 | 47篇 |
1998年 | 65篇 |
1997年 | 56篇 |
1996年 | 57篇 |
1995年 | 45篇 |
1994年 | 46篇 |
1993年 | 32篇 |
1992年 | 51篇 |
1991年 | 45篇 |
1990年 | 30篇 |
1989年 | 46篇 |
1988年 | 45篇 |
1987年 | 33篇 |
1986年 | 36篇 |
1985年 | 21篇 |
1984年 | 16篇 |
1983年 | 17篇 |
1982年 | 15篇 |
1980年 | 16篇 |
1979年 | 20篇 |
1978年 | 15篇 |
1977年 | 13篇 |
1976年 | 13篇 |
1975年 | 12篇 |
1971年 | 11篇 |
1969年 | 10篇 |
1934年 | 13篇 |
排序方式: 共有2274条查询结果,搜索用时 31 毫秒
61.
Thomas Helbing Eva‐Maria Herold Alexandra Hornstein Stefanie Wintrich Jennifer Heinke Sebastian Grundmann Cam Patterson Christoph Bode Martin Moser 《The Journal of pathology》2013,231(1):105-116
Epithelial injury is a central finding in pulmonary disease and is accompanied by disruption of epithelial barrier function, leading to pulmonary oedema and inflammation. Injured epithelial cells lose their properties and gain mesenchymal characteristics, a phenotypic switch that contributes to lung remodelling after injury. Here we studied bone morphogenetic protein (BMP) signalling and, in particular, the role of BMP2 and the BMP modulator BMPER in injured lung epithelium. Increased BMP activity, reflected by up‐regulation of the Smad1/5–Id1 axis, is detected after injury of lung epithelium in vitro and in vivo. Two members of the BMP family, BMP2 and BMPER, have opposing effects. BMP2 is up‐regulated after epithelial injury and causes epithelial dysfunction and hyperpermeability, mediated by the Smad1/5–Id1‐dependent down‐regulation of E‐cadherin. In contrast, BMPER expression is decreased following injury, which in turn impairs epithelial integrity, characterized by reduction of E‐cadherin and epithelial leakage in vitro and in vivo. High levels of BMPER antagonized BMP2‐Smad5–Id1 signalling and prevented BMP2‐mediated decrease of E‐cadherin and hyperpermeability, suggesting that BMPER restores epithelial homeostasis. Supporting this notion, pharmacological inhibition of BMP signalling by LDN193189 prevented reduction of E‐cadherin and disruption of epithelial barrier function. Inhibition of excessive BMP activation could be a new approach to restore epithelial integrity and prevent disruption of epithelial barrier function after lung injury. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献
62.
von Mühlen Carlos
Alberto Garcia-De La Torre Ignacio Infantino Maria Damoiseaux Jan Andrade Luis E. C. Carballo Orlando Gabriel Conrad Karsten Francescantonio Paulo Luiz Carvalho Fritzler Marvin J. Herold Manfred Klotz Werner de Melo Cruvinel Wilson Mimori Tsuneyo Satoh Minoru Musset Lucile Chan Edward K. L. 《Immunologic research》2021,69(6):594-608
Immunologic Research - Results of the anti-nuclear antibodies-indirect immunofluorescence assay (anti-cell antibodies test) on HEp-2 cell substrates should be communicated to clinicians in a... 相似文献
63.
Xinying Zhou Robert A. de Man Robert J. de Knegt Herold J. Metselaar Maikel P. Peppelenbosch Qiuwei Pan 《Reviews in medical virology》2013,23(5):295-304
Hepatitis E virus (HEV) infection has emerged as a global public health issue. Although it often causes an acute and self‐limiting infection with low mortality rates in the western world, it bears a high risk of developing chronic hepatitis in immunocompromised patients with substantial mortality rates. Organ transplant recipients who receive immunosuppressive medication to prevent rejection are thought to be the main population at risk for chronic hepatitis E. Therefore, there is an urgent need to properly evaluate the clinical impact of HEV in these patients. This article aims to review the prevalence, infection course, and management of HEV infection after solid organ transplantation by performing a comprehensive literature review. In addition, an in‐depth emphasis of this clinical issue and a discussion of future development are also presented. Copyright © 2013 John Wiley & Sons, Ltd. 相似文献
64.
65.
Amplification of genes encoding human myeloid membrane antigens after DNA-mediated gene transfer 总被引:2,自引:0,他引:2
Spontaneous amplification of genes encoding two different human myeloid surface antigens was observed after DNA-mediated gene transfer of cellular DNA from the human myeloid cell line HL-60 into NIH-3T3 mouse fibroblasts. Transformed recipient cells with highly amplified expression of either of two donor membrane polypeptides, gp150 or p67, were isolated with a fluorescence-activated cell sorter (FACS), using monoclonal antibodies specific for human myeloid cells. Immunoprecipitation of enzymatically radioiodinated polypeptides from the surface of transformed NIH-3T3 cells confirmed that expression of these proteins was amplified tenfold to 20-fold in comparison to their expression on human myeloid cell lines. The cellular DNA of cloned secondary and tertiary transformants expressing high levels of gp150 and p67 contained amplified sets of DNA restriction fragments that hybridized with human repetitive DNA sequences. Cytogenetic analysis of subclones overexpressing gp150 revealed extrachromosomal double minutes (DMs), whose presence correlated with the unstable expression of the membrane polypeptide. Human sequences in gp150-positive clones did not localize to chromosomes, consistent with their association with extrachromosomal DMs. By contrast, p67-positive subclones stably expressed the antigen, and in situ hybridization to metaphase spreads demonstrated that amplified human DNA sequences were integrated into a specific marker chromosome. Cytogenetic analysis of the parental NIH- 3T3 subclone used in these studies disclosed DMs in a low percentage of metaphases, suggesting that the recipient cells have a propensity for amplifying donor DNA. 相似文献
66.
Sebaceous carcinoma is a rare cutaneous malignancy, commonly affecting the eyelids. This case highlights a patient who presented with sebaceous carcinoma of the right upper lip with extensive involvement of the soft tissues of the head and neck. As part of the initial investigation, ultrasound was requested. This case demonstrates the ultrasound features of sebaceous carcinoma as well as revising the normal ultrasound anatomy of the upper lip and muscles of the cheek. 相似文献
67.
Elevated numbers of primitive Philadelphia chromosome-positive (Ph+) progenitors, including long-term culture-initiating cells (LTC-IC) as well as colony-forming cells (CFC), have been previously described in the blood of patients with chronic myeloid leukemia (CML) in chronic phase with high white blood cell counts. In the present study, which focused primarily on an analysis of circulating progenitors present in such patients at diagnosis, we discovered the frequent and occasionally exclusive presence of circulating normal (Ph-) LTC-IC, often at levels above those seen for LTC-IC in the blood of normal individuals. The presence of detectable numbers of circulating Ph- LTC-IC was independent of the fact that the same peripheral blood samples also contained elevated numbers of predominantly or exclusively Ph+ CFC. Interestingly, both the Ph+ and Ph- LTC-IC in these samples were CD34+CD71- and variably CD38- and Thy-1+, as previously documented for LTC-IC in normal marrow. Thus, neither CD38 nor Thy-1 expression was useful for discriminating between Ph+ and Ph- LTC-IC in mixed populations. Nevertheless, an association of these phenotypes with LTC- IC function did allow highly enriched (> 5% pure) suspensions of either Ph+ or Ph- LTC-IC to be obtained from selected samples of CML blood in which the initial LTC-IC population was either predominantly Ph+ or Ph- , respectively. These findings suggest that the mechanisms causing mobilization of leukemic stem cells in untreated CML patients may affect their normal counterparts. They also indicate a possible new source of autologous cells for the support of intensive therapy of CML patients. Finally, they provide a method for obtaining the most highly purified populations of Ph+ LTC-IC described to date. This method should be useful for further analyses of the molecular activities of these very primitive neoplastic cells. 相似文献
68.
Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre 总被引:6,自引:0,他引:6
Herold C Reck T Fischler P Ott R Radespiel-Troeger M Ganslmayer M Hohenberger W Hahn EG Schuppan D 《Liver》2002,22(1):23-28
BACKGROUND/AIM: Only a few follow up data are available for patients with hepatocellular carcinoma (HCC) in Europe and the USA. Therefore, we analysed all HCC patients admitted to our hospital between 1988 and 1999. METHODS: We documented aetiology, stage (HCC: Okuda and UICC classifications, liver cirrhosis: Child-Pugh score), and diagnostic and therapeutic measures of 281 consecutive HCC patients. Survival time was calculated as a function of staging and therapy. RESULTS: Cirrhosis was diagnosed in all patients. Seventy-two patients underwent liver resection, 28 liver transplantation, 31 transarterial chemoembolization and 14 percutaneous ethanol injection. One hundred and thirty-six patients received no treatment. The Okuda and the Child-Pugh classification predicted a significant decrease of median survival time, whereas the UICC classification was less powerful. CONCLUSIONS: HCC occurred only in patients with liver cirrhosis. Survival time correlated with therapy (or no therapy) and with the Child-Pugh Score. In European patients the Okuda classification is superior to the UICC classification and should be compared to novel classification systems. 相似文献
69.
70.
Kevan C. Herold Sahar Usmani-Brown Tara Ghazi Jasmin Lebastchi Craig A. Beam Melena D. Bellin Michel Ledizet Jay M. Sosenko Jeffrey P. Krischer Jerry P. Palmer the Type Diabetes TrialNet Study Group 《The Journal of clinical investigation》2015,125(3):1163-1173
Role of the funding source: Funding from the NIH was used for support of the participating clinical centers and the coordinating center. The funding source did not participate in the collection or the analysis of the data.BACKGROUND. The β cell killing that characterizes type 1 diabetes (T1D) is thought to begin years before patients present clinically with metabolic decompensation; however, this primary pathologic process of the disease has not been measured.METHODS. Here, we measured β cell death with an assay that detects β cell–derived unmethylated insulin (INS) DNA. Using this assay, we performed an observational study of 50 participants from 2 cohorts at risk for developing T1D from the TrialNet Pathway to Prevention study and of 4 subjects who received islet autotransplants.RESULTS. In at-risk subjects, those who progressed to T1D had average levels of unmethylated INS DNA that were elevated modestly compared with those of healthy control subjects. In at-risk individuals that progressed to T1D, the observed increases in unmethylated INS DNA were associated with decreases in insulin secretion, indicating that the changes in unmethylated INS DNA are indicative of β cell killing. Subjects at high risk for T1D had levels of unmethylated INS DNA that were higher than those of healthy controls and higher than the levels of unmethylated INS DNA in the at-risk progressor and at-risk nonprogressor groups followed for 4 years. Evaluation of insulin secretory kinetics also distinguished high-risk subjects who progressed to overt disease from those who did not.CONCLUSION. We conclude that a blood test that measures unmethylated INS DNA serves as a marker of active β cell killing as the result of T1D-associated autoimmunity. Together, the data support the concept that β cell killing occurs sporadically during the years prior to diagnosis of T1D and is more intense in the peridiagnosis period.TRIAL REGISTRATION. Clinicaltrials.gov .FUNDING. Funding was from the NIH, the Juvenile Diabetes Research Foundation, and the American Diabetes Association. NCT00097292相似文献